Low Versus Standard Intensity Heparin Protocols in Adults Maintained on Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study
Journal of Pharmacy Practice · 2025
DOI: 10.1177/08971900241285248 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Pharmacy Practice, 2025. Verfasst von Rachel C Robinson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Wellstar MCG Health, Augusta, GA, USA. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Heparin, Anticoagulants, Hemorrhage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background
Patients maintained on extracorporeal membrane oxygenation (ECMO) often require systemic anticoagulation to prevent circuit clotting and systemic thromboembolic complications. The optimal intensity of anticoagulation to balance the risk of bleeding and prevention of thrombotic complications in this patient population is not well described.
Objective
To compare bleeding events in patients on ECMO anticoagulated with standard vs low intensity heparin protocols.
Methods
This single-center, retrospective cohort study included adult patients on VA- or VV-ECMO and anticoagulated with low or standard intensity heparin protocols. The primary outcome was the incidence of major bleeding; secondary outcomes included the incidence of minor bleeding, thrombotic complications, heparin-induced thrombocytopenia, in-hospital mortality, time in therapeutic range, anti-Xa correlation with aPTT, intensive care unit and hospital lengths of stay, oxygenator exchanges, and rate of protocol switching.
Results
A total of 27 patients (14 low intensity, 13 standard intensity) were included. There were six major bleeding events in the low intensity group and four in the standard intensity group ( P = 0.69); there were four minor bleeding events in the low intensity group and five in the standard intensity group ( P = 0.69). Seven patients in the standard intensity group switched protocols; zero patients in the low intensity group switched protocols ( P = 0.002). There were no differences in any other outcomes.
Conclusions
There was no difference in the incidence of any bleeding or thrombotic events when using a low vs standard intensity heparin protocol in patients on ECMO. A low intensity heparin strategy for patients on ECMO may be feasible and safe.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Wellstar MCG Health, Augusta, GA, USA.
- Department of Respiratory Therapy, Wellstar MCG Health, Augusta, GA, USA.
- Department of Surgery, Wellstar MCG Health & Medical College of Georgia, Augusta, GA, USA.
- Department of Anesthesia & Perioperative Medicine, Wellstar MCG Health & Medical College of Georgia, Augusta, GA, USA.
- Department of Population Health Sciences, Division of Biostatistics and Data Science, Medical College of Georgia, Augusta University, Augusta, GA, USA.
ORCID-Profile: Rachel C Robinson, Ashley N Taylor, Jennifer L Waller
Zitieren
APA
Robinson, R. C., Taylor, A. N., Cato, A. W., Patel, V. S., Waller, J. L., & Wayne, N. B. (2025). Low Versus Standard Intensity Heparin Protocols in Adults Maintained on Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900241285248
Vancouver
Robinson RC, Taylor AN, Cato AW, Patel VS, Waller JL, Wayne NB. Low Versus Standard Intensity Heparin Protocols in Adults Maintained on Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study. Journal of Pharmacy Practice. 2025. doi:10.1177/08971900241285248
BibTeX
@article{Robinson2025,
author = {Robinson, Rachel C and Taylor, Ashley N and Cato, Amy W and Patel, Vijay S and Waller, Jennifer L and Wayne, Nathaniel B},
title = {Low Versus Standard Intensity Heparin Protocols in Adults Maintained on Extracorporeal Membrane Oxygenation: A Retrospective Cohort Study},
journal = {Journal of Pharmacy Practice},
year = {2025},
doi = {10.1177/08971900241285248}
}
EUVIMED